Trinity Biotech PLC (TRIB) stock
TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 1/30
$5.83−0.18 (-3.08%)
Close on Nov 18, 2026Market cap $108.99MP/E –Yield –
Trinity Biotech pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Trinity Biotech's pe ratio was 334.5× on Feb 28, 2023, against 232.8× a year earlier. Over the last 2 years it ranged from 232.8× to 506.3×, with a median of 386.9×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Feb 28, 2023 | 334.5× | +20.6 |
| 2022 | Dec 30, 2022 | 313.9× | +81.2 |
| 2017 | Feb 28, 2017 | 232.8× | −28.3 |
| 2016 | Dec 30, 2016 | 261.1× | – |
See a number that looks wrong?